Prior to HIFU, MRI of the perineum is performed to examine the size, number, and exact location of fibroids and evaluate the likelihood of uterine sarcoma. 12 In this way, the anatomical structures of the uterus and surrounding organs can be accurately identified. Intravenous conscious sedation was conducted to the patient to minimize their movement
Uterine fibroids the most common benign gynecological tumors that can cause abnormal menstrual bleeding, menstrual cramps, pelvic discomfort, infertility, urinary frequency and others. Although surgical removal of the uterus is the definitive treatment, some patients choose to keep their uterus in place. For this reason, minimally invasive treatment options have been suggested such as uterine artery occlusion, high-frequency ablation and others. 1 However, these interventions are still in the experimental phase.
In recent years, high intensity focused ultrasound (HIFU) has attracted much attention in obstetrics and gynecology as a non-surgical modality for treating uterine fibroids. In the early years, HIFU technique determined the therapeutic range of fibroids using magnetic resonance imaging (MRI) and monitored the degree of cauterization. On average, fibroid volume was reduced to half at 3 months, 1/3 at 6 month, and 1/4 at 12 months in size after the treatment. Moreover, patients were found to experience symptom improvement from 3 to 6 months on average.
The nonperfusion area, the percentage of the fibroid volume being ablated, on contrast-enhanced T1-weighed MRI was found to show substantial symptom improvement. 5, 8 MR-HIFU has a mean nonperfused volume of 16% to 67%, whereas that of ultrasound-guided HIFU ranges between 80% and 89%. 10, 11, 18 When using ultrasound-guided HIFU, the most crucial HIFU was first approved for premenopausal women with no further plans for pregnancy. However, the use of this therapy was excluded from the absolute ban policy since 2009, as successful child-bearing and vaginal birth had been proved multiple times. In Europe, HIFU using approved devices is allowed for patients who wish to preserve their fertility. 19 Since HIFU is still an unfamiliar modality in obstetrics and gynecology, there are difficulties in fully informing patients about its therapeutic effects. The purposes of this review are to provide a reference data for patients about the effectiveness of HIFU for managing uterine fibroids and optimal treatment options to select from.
